Fitbit to support Singapore’s public health and smart nation programs
Category: #health  By Mateen Dalal  Date: 2019-08-23
  • share
  • Twitter
  • Facebook
  • LinkedIn

Fitbit to support Singapore’s public health and smart nation programs

Health population initiatives will be powered by Fitbit wearable devices and new Premium service

Fitbit Inc., a San Francisco based tech company, has announced that it will partner with the Health Promotion Board (HPB) of Singapore for a healthy population project in association with a Smart Nation initiative by Singapore.

The Health promotion Board is a government agency in Singapore that reportedly implements programs and policies in order to improve the nation’s health.

Apparently, this is the  first key integration of Fitbit’s digital wearables and health platform into a public health program on a global level. Live Healthy SG was specifically designed by Fitbit and HPB for Singapore that would harness behavior insights, analytics and technology to help the citizens of the country get healthier through sustained and meaningful change in behavior.

The initiative will be engaging people of different age groups with various level of health concerns to use Fitbit devices and its new premium service, which will be launched in select markets around the world.

Singapore is known as the one of the healthiest countries in the world and is recognized for its efficient system for healthcare, that comprises world class infrastructure, skilled healthcare talent and high quality health services. However, the country has been facing an increase in chronic conditions like cancer, hypertension and Type 2 diabetes.

CEO of Health Promotion Board, Zee Yoong Kang stated that they intend to be working with industry innovators like Fitbit to use technology to provide citizens with personal health advice as well as nudge them to take care of their own health.

Participants will benefit from plans laid down by Fitbit to incorporate machine learning and artificial intelligence for encouraging healthy eating, better sleep quality and physical activity. The health promotion programs by HPB can be enriched with the help of all the insights gathered, Kang added.

Reportedly, HPB will be leveraging its outreaching channels in order to support Fitbit in promoting participation for its program. The participants will have a clear consent process that will indicate if they will agree to share data in the program with HPB.

 

Source Credit- https://investor.fitbit.com/press/press-releases/press-release-details/2019/Fitbit-Collaborates-with-Singapores-Health-Promotion-Board-on-Population-Based-Public-Health-Initiative-in-Singapore/default.aspx

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market
Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market
By Mateen Dalal

Aesthetic medicine is increasingly being used for the treatment of physical impairments such as skin discoloration, excessive fat, scars, skin laxity, wrinkles, cellulite, and liver spots. Customer are seen demanding for resurfacing and non-invasive ...

Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial
Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial
By Mateen Dalal

There is a substantial rise in the number of people affected with pulmonary diseases like asthma. Various pharmaceutical companies in the world are combining their capabilities to find treatments for serious pulmonary diseases to address the needs of...

AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
By Mateen Dalal

As cases of neurodegenerative diseases like Alzheimer’s and Parkinson’s are on a rise, biopharmaceutical firms are actively engaging in developing new clinical drugs. Companies are also gaining increased funding from partners to further t...